REVA Medical - Top 20 VC deals of 2007

Company: REVA Medical
Based: San Diego
Amount: $42M
Investors: Brookside International, Cerberus Capital Management, Domain Associates, Medtronic, Pequot Capital Management, Undisclosed Investor

Scoop: REVA Medical is a medical device company. It's lead product is RESORB--a bioresorbable coronary stent that is designed to fulfill the temporary need for a stent and then fade away. In June of 2007 the company began clinical trials of the stent for coronary artery disease. A second trial is planned to study the safety of the REVA Paclitaxel-Coated Bioresorbable Stent. Funds from the VC round are being used to support trials of the stent.

REVA Medical - Top 20 VC deals of 2007

Suggested Articles

The drug failed a futility analysis in March, but Biogen resurrected it after factoring in data generated after the cutoff for the interim assessment.

The negative top-line data deal a big blow to the prospects of a drug analysts tipped to achieve blockbuster sales if it cleared phase 3.

Intrepida Bio launched with $9.5 million from Sofinnova and Canaan Partners to develop anti-BAG3 antibodies for the treatment of cancer.